Furthermore, neurodegeneration-associated markers, such as Alzheimer’s disease (AD)-related molecules and neurogranin hold prognostic significance, particularly in cognitive outcomes for people with MCI and PD [9]. This evidence concerns the gene NRGN and Parkinson disease.